The French conducted a study regarding the use of somatropin ( recombinant growth hormone) in children. The study called the SAghE (Sante Adulte GH Enfant) was conducted on over 7000 patients that received this treatment from 1985 to 1996. They found that 93 deaths had occurred in the group that had been treated versus 70 that were expected of the general population; almost 30% more. However, the Food and Drug Administration is telling those still on the treatment to continue it and is looking into the matter
Have a look at this link:
. http://www.fda.gov/Drugs/DrugSafety/ucm237773.htm
No comments:
Post a Comment